Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) reported an increase of 1.8% in the consolidated profits during fiscal year 2018 compared to the previous year.

Net earnings grew to EGP 701.31 million in FY18 from EGP 688.87 million in FY17, according to a bourse disclosure on Thursday.

EIPICO recorded a growth of 11.41% in sales to EGP 2.815 billion in fiscal year 2018 from EGP 2.527 billion in FY17.

During 2018, the pharmaceutical manufacturer reported standalone profits worth EGP 651.7 million compared to EGP 651.4 million in 2017.

Meanwhile, the standalone sales went up to EGP 2.7 billion in FY18 from EGP 2.4 billion in the previous year.